Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Vox Sang ; 108(2): 178-85, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25469720

ABSTRACT

BACKGROUND AND OBJECTIVES: Repeated blood donation produces iron deficiency. Changes in dietary iron intake do not prevent donation-induced iron deficiency. Prolonging the interdonation interval or using oral iron supplements can mitigate donation-induced iron deficiency. The most effective operational methods for reducing iron deficiency in donors are unknown. MATERIALS AND METHODS: 'Strategies To Reduce Iron Deficiency' (STRIDE) was a two-year, randomized, placebo-controlled study in blood donors. 692 donors were randomized into one of two educational groups or one of three interventional groups. Donors randomized to educational groups either received letters thanking them for donating, or, suggesting iron supplements or delayed donation if they had low ferritin. Donors randomized to interventional groups either received placebo, 19-mg or 38-mg iron pills. RESULTS: Iron deficient erythropoiesis was present in 52·7% of males and 74·6% of females at enrolment. Adverse events within 60 days of enrolment were primarily mild gastrointestinal symptoms (64%). The incidence of de-enrolment within 60 days was more common in the interventional groups than in the educational groups (P = 0·002), but not more common in those receiving iron than placebo (P = 0·68). CONCLUSION: The prevalence of iron deficient erythropoiesis in donors enrolled in the STRIDE study is comparable to previously described cohorts of regular blood donors. De-enrolment within 60 days was higher for donors receiving tablets, although no more common in donors receiving iron than placebo.


Subject(s)
Anemia, Iron-Deficiency/prevention & control , Blood Donors , Iron Deficiencies , Iron, Dietary/therapeutic use , Adult , Dietary Supplements , Double-Blind Method , Erythropoiesis , Female , Humans , Iron/blood , Iron, Dietary/administration & dosage , Iron, Dietary/adverse effects , Male
3.
J Am Chem Soc ; 123(26): 6308-13, 2001 Jul 04.
Article in English | MEDLINE | ID: mdl-11427055

ABSTRACT

The new N5+ salt, N5+ SbF(6)(-), was prepared from N(2)F(+)SbF(6)(-) and HN(3) in anhydrous HF solution. The white solid is surprisingly stable, decomposing only at 70 degrees C, and is relatively insensitive to impact. Its vibrational spectrum exhibits all nine fundamentals with frequencies that are in excellent agreement with the theoretical calculations for a five-atomic V-shaped ion of C(2)(v)symmetry. The N5+ Sb(2)F(11)(-) salt was also prepared, and its crystal structure was determined. The geometry previously predicted for free gaseous N5+ from theoretical calculations was confirmed within experimental error. The Sb(2)F(11)(-) anions exhibit an unusual geometry with eclipsed SbF(4) groups due to interionic bridging with the N5+ cations. The N5+ cation is a powerful one-electron oxidizer. It readily oxidizes NO, NO(2), and Br(2) but fails to oxidize Cl(2), Xe, or O(2).

4.
Plast Reconstr Surg ; 100(3): 682-4, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9283568

ABSTRACT

Supernumerary nostril is an extremely rare congenital anomaly with sporadic reports of its occurrence in the literature. Associated congenital anomalies have not been present in the cases described. The treatment is excision of the nostril, using the technique of a fistulectomy, and associated procedures to correct a bifid nasal tip or wide columella base. We describe our experience with this anomaly in an adult male, who had features of an incomplete naso-ocular cleft. We treated it by excising the accessory nostril, repositioning the displaced alar base, and providing skin and lining, which were both deficient, by local flaps.


Subject(s)
Maxilla/abnormalities , Nose/abnormalities , Orbit/abnormalities , Adult , Humans , Male , Nose/surgery , Rhinoplasty
SELECTION OF CITATIONS
SEARCH DETAIL
...